Putting Patients First Blog

JUNE 26, 2025

This step would ensure that real-world considerations, such as off-label uses and quality-of-life impacts, are factored into revised pricing decisions. 4 Centers for Medicare & Medicaid Services, National Provider Communication Standards , April 15, 2025, https ://www.cms.gov/files/document/national-provider-communication-standards.pdf.

Drug Pricing 52

Drug Pricing Communication Drug Development Documentation 52

Big Molecule Watch

JULY 22, 2024

The FTC asserts that “PBMs exert substantial influence over independent pharmacies” and “oversee critical decisions about access to and affordability of medications without transparency or accountability to the public.” Humana Pharmacy Solutions, Inc.; Humana Pharmacy Solutions, Inc.; OptumRx, Inc.; OptumRx, Inc.;

Independent Pharmacies 59

Independent Pharmacies Documentation Labelling Biosimilars 59

pharmacy mentor

OCTOBER 22, 2024

Compliance and Regulatory Adherence Pharmacies operate in a highly regulated environment, and compliance with various laws and guidelines is paramount. UPW helps pharmacies adhere to these regulations by automating many of the compliance-related tasks.

Communication 52

Communication Prescription Management Medication Dispensing Online Pharmacies 52

Putting Patients First Blog

JULY 2, 2024

The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Off-label usage often emerges from real- world clinical practice and patient experiences, which might not be reflected in the guidelines. Blendon, R., hstc=117268889.c6acac5669d4f1e6063a774e6d96c6b5.1716560813145.1716560813145.1716560813145.1&

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Ramblings of a pharmacist

OCTOBER 26, 2022

To all external observers, the medication looked legitimate – it bore a normal label, it was the right size, the product tracing documentation was received in good order. Biktarvy® and other HIV drugs are generally labeled to “dispense in original packaging” so the pharmacist never broke the seal on the bottle.

Documentation 40

Documentation Labelling Independent Pharmacies Community Pharmacies 40